Protagonist Therapeutics Inc (PTGX)
Receivables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
Receivables | US$ in thousands | — | — | — | — | — |
Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $434,433K ÷ $—K
= —
Based on the data provided, Protagonist Therapeutics Inc does not have any information available for the receivables turnover for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. Receivables turnover ratio is a key metric that indicates how efficiently a company is collecting payments from its customers. The absence of data on receivables turnover for these years makes it challenging to assess the company's effectiveness in managing its accounts receivable and collecting payments in a timely manner. It is important for the company to track and report this information to gain insights into its liquidity and operational efficiency.
Peer comparison
Dec 31, 2024